Bluebirdbio stock.

Zolmax • 12 days ago. Track Bluebird bio Inc (BLUE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get …24 thg 10, 2023 ... Yes, a replay of the webcast will be available on the bluebird website for 90 days following the event. Stock BLUE logo.Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has approved Abecma (idecabtagene vicleucel; ide-cel) as the first B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of adult patients …bluebird bio Inc (BLUE) stock is trading at $4.06 as of 1:23 PM on Friday, Dec 1, a gain of $0.23, or 6.15% from the previous closing price of $3.82. The stock has traded between $3.76 and $4.18 so far today. Volume today is less active than usual. So far 2,498,462 shares have traded compared to average volume of 4,012,219 shares.The market expects Bluebird Bio (BLUE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2022. This widely-known consensus ...

A high-level overview of 2seventy bio, Inc. (TSVT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Latest news about bluebird bio, Inc. Wedbush Lowers bluebird bio's Price Target to $5 From $7, Maintains Neutral Rating. Nov. 08. MT. Transcript : Bluebird bio, Inc., Q3 2023 Earnings Call, Nov 07, 2023. Nov. 07. CI. Earnings Flash (BLUE) BLUEBIRD BIO Reports Q3 Revenue $12.4M, vs. Street Est of $13.4M. Nov. 07.

24 thg 10, 2023 ... Yes, a replay of the webcast will be available on the bluebird website for 90 days following the event. Stock BLUE logo.Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Latest BLUE News. View. bluebird bio (BLUE, $4.26) RSI Indicator left the overbought zone on December 01, 2023. Tickeron - Stocks • about 12 hours ago. bluebird bio (BLUE, $3.66) Stochastic Oscillator left the overbought zone on November 21, 2023. Tickeron - Stocks • 11 days ago. bluebird bio Target of Unusually Large Options Trading ...Nov 30, 2023 · bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.

Bluebird Bio. Market Cap. $419M. Today's Change. (11.99%) $0.41. Current Price. $3.83. Price as of November 20, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ...

View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

[email protected]. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. [email protected]. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low:Earnings for bluebird bio are expected to decrease in the coming year, from ($1.81) to ($1.84) per share. bluebird bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates. Read More.View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.According to the issued ratings of 12 analysts in the last year, the consensus rating for bluebird bio stock is Hold based on the current 1 sell rating, 5 hold ratings and 6 buy ratings for BLUE. The average twelve-month price prediction for bluebird bio is $7.62 with a high price target of $13.00 and a low price target of $3.00. Learn more on ...10 stocks we like better than Bluebird Bio When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has ...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events. The severity of sickle cell disease, and its impact on patients and caregivers, has been underappreciated and overlooked for far too long.Real time Bluebird Bio (BLUE) stock price quote, stock graph, news & analysis. bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thalassemia (TDT), a rare genetic blood disorder, and has been approved for use by the European Medicines Agency.Current Job Openings at bluebird bio. Senior Director, Pharmacovigilance. Associate Director, Regulatory Strategy (Postmarketing) Director, Regulatory Affairs Strategy (Postmarketing) Associate Director, Patient Navigator-West (CA, WA, AZ, UT, and CO) Associate Director, Apheresis Strategy and Operations. Associate Director, Patient …bluebird bio Inc (BLUE) stock is higher by 0.26% while the S&P 500 is down -0.11% as of 11:47 AM on Thursday, Nov 30. BLUE has risen $0.01 from the previous closing price of $3.86 on volume of 1,460,801 shares. Over the past year the S&P 500 is up 14.86% while BLUE is down -49.41%. BLUE lost -$0.74 per share in the over the last 12 …

Dec 20, 2021 · Shares of Bluebird Bio ( BLUE -3.00%) were plunging 22.3% as of 10:41 a.m. ET on Monday. The big drop came after the company announced that the Food and Drug Administration (FDA) placed its ... According to the issued ratings of 12 analysts in the last year, the consensus rating for bluebird bio stock is Hold based on the current 1 sell rating, 5 hold ratings and 6 buy ratings for BLUE. The average twelve-month price prediction for bluebird bio is $7.62 with a high price target of $13.00 and a low price target of $3.00. Learn more on ...

If you're looking for growth stocks that are at the spear's tip of innovation, you might want to check out Bluebird Bio (BLUE 11.52%) and Arista Networks (ANET-1.40%).Aug 28, 2023 · Bluebird Bio (BLUE 11.52%), a leader in gene therapy, could be a great pick for growth investors.This company has two gene therapies that the U.S. Food and Drug Administration (FDA) has approved ... View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.SOMERVILLE, Mass.--(BUSINESS WIRE)--Jan. 18, 2023-- bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today announced that it has commenced an underwritten public offering of 20,000,000 shares of its common stock. bluebird also intends to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of its …8 thg 5, 2019 ... ...more. Alliance for Regenerative Medicine. 6.53K. Subscribe. 6.53K subscribers. 4. Share. Save. Report. Comments. thumbnail-image. Add a ...Shares Out 109.34M 10 Day Average Volume 4.55M Dividend - Dividend Yield - Beta 0.97 YTD % Change -45.23 RATIOS/PROFITABILITY EPS (TTM) -0.74 P/E (TTM) -5.09 Fwd …bluebird bio Stock Price, News & Analysis (NASDAQ:BLUE) $3.89 +0.10 (+2.64%) (As of 11/24/2023 ET) Compare Today's Range $3.75 $4.13 50-Day Range …Bluebird Bio (BLUE) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.72. ... bluebird bio, Inc. (BLUE) : Free Stock Analysis Report. Cardiff ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.bluebird bio (BLUE) Stock Gains 25.6% in a Month: Here's How. bluebird bio (BLUE) rises 25.6% in past thirty days on upbeat earnings results and promising progress with its approved therapies.

What happened. Shares of gene therapy company Bluebird Bio ( BLUE -6.90%) fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market ...

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

Apr 6, 2023 · The case for buying the dip isn't exactly a slam dunk. With the stock down 52% in the last three months, Bluebird Bio ( BLUE -1.28%) shareholders are bound to be feeling pretty antsy. Between the ... Shares of bluebird bio (. BLUE Quick Quote. BLUE - Free Report) have increased by 25.6% in a month compared with the industry ’s growth of 0.2%. Last month, bluebird posted better-than-expected ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share …Bluebird Bio drives gene therapy stocks higher after FDA review. Jun. 07, 2022 3:59 PM ET bluebird bio, Inc. ... Bluebird bio has posted its best intraday gain since 2014.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $13.31M. -78.9%. Market Cap / Employee. The market cap of a ...What happened. Shares of the gene therapy pioneer Bluebird Bio ( BLUE -1.04%) have been under heavy pressure this week. The biotech's stock dropped by a noteworthy 28.8% during the first three and ...Let's look at Bluebird Bio (BLUE 2.64%). Per Wall Street's analysts, its shares could rise 118% by this time next year despite losing 51% of their value so far in 2023.Bluebird Bio. Market Cap. Current Price. $3.10. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...

bluebird bio specializes in gene therapies for severe genetic diseases and has 2 FDA-approved products. EV/Sales multiple appears cheap. Find out why BLUE stock is a Buy.Shares of Bluebird Bio ( BLUE -3.00%) were plunging 22.3% as of 10:41 a.m. ET on Monday. The big drop came after the company announced that the Food and Drug Administration (FDA) placed its ...10 stocks we like better than Bluebird Bio When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has ...Latest BLUE News. View. bluebird bio (BLUE, $4.26) RSI Indicator left the overbought zone on December 01, 2023. Tickeron - Stocks • about 12 hours ago. bluebird bio (BLUE, $3.66) Stochastic Oscillator left the overbought zone on November 21, 2023. Tickeron - Stocks • 11 days ago. bluebird bio Target of Unusually Large Options Trading ...Instagram:https://instagram. stock toyotagood natural gas stocksreal estate investment appripster View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. digital life insurance companieshow to purchase preferred stock On May 9, bluebird bio will be reporting earnings Q1. Analysts are expecting losses per share of $0.370. Go here to follow bluebird bio stock price in real-time on Markets Insider. best investments after retirement Bluebird Bio drives gene therapy stocks higher after FDA review. Jun. 07, 2022 3:59 PM ET bluebird bio, Inc. ... Bluebird bio has posted its best intraday gain since [email protected]. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. [email protected]. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low: